Notably, we discovered novel miRNAs that target MDM4 and MDM2; this study enhances our understanding of the YAP1/Hippo pathway and the functions of miRNAs as novel therapeutic targets in breast cancer (Fig. 7). Here, MDM2 is linked to breast cancer.